Walhalla, SCNCT07731399Now EnrollingIRB Ready

Type 2 Diabetes Clinical Trial in Walhalla, SC

Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Walhalla. Study-provided care at no cost to qualified participants.

Sponsored by Guardian Research Network, Inc.

Quick Self-Assessment

See if you qualify for this Walhalla location

Preparing your pre-screening questions…

Expert Care in Walhalla

Access type 2 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 2 diabetes treatment provided free

Apply for This Walhalla Location

Check if you qualify for this type 2 diabetes clinical trial in Walhalla, SC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Walhalla

    Convenient for SC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Walhalla site if eligible
  4. 4Begin participation

About This Type 2 Diabetes Study in Walhalla

The primary purpose of this study is to use multiomic data in combination with clinical assessments, electronic health records, cognitive and mood assessments, wearable technologies and lifestyle/behavioral data to identify data elements or combinations of data elements with strong positive or negative correlation to CKD diagnosis and/or progression in Type 2 Diabetes (T2D) patients. Achieving this aim will allow researchers and physicians to significantly improve the prediction of health trajectories of and formulate novel strategies to potentially prevent, treat or reverse T2D. South Carolina Medicaid-enrolled patients diagnosed with T2D and a smaller subset of non-T2D SC Medicaid patients may participate in this study. Participants who complete required procedures will be compensated for their time and transportation, may keep their study-provided Fitbit device to help maintain their healthcare improvement journey, and will have a personal Certified Diabetes Educator to consult and assist with managing their diabetes diagnosis.

Sponsor: Guardian Research Network, Inc.

Who Can Participate

Inclusion Criteria

All Participants:
40 to 70 years of age (inclusive) at enrollment
Enrolled as Medicaid recipients
Ability to provide informed consent and authorization for release of relevant protected health information or personal data
Ability to provide a blood sample(s) of up to 70 mL and other required biospecimens, including genetic samples. T2D Group: • Current diagnosis of Type 2 diabetes OR a blood level of hemoglobin A1c equal to or greater than 6.5% at any time within the past 12 months Control Group:
Blood level of hemoglobin A1c less than or equal to 5.6% at time of enrollment
No diagnosis of Type 2 diabetes

Exclusion Criteria

Pregnancy at time of enrollment (by self-report of pregnancy status)
Lack of fluency in spoken and written English
Type 1 diabetes or any other type of diabetes besides Type 2 diabetes
Active cancer diagnosis or cancer that achieved complete remission within three (3) years prior to enrollment, other than non-melanoma skin cancer (e.g. malignant basal cell neoplasm of skin and/or squamous cell carcinoma of skin)
Major Adverse Cardiovascular Events within two (2) years prior to enrollment
Chronic Obstructive Pulmonary Disease
Cognitive impairment or neurodegenerative diseases (e.g., Alzheimer's disease, dementia, multiple sclerosis, Parkinson's disease, etc.)
Pancreatitis or other diseases of the pancreas (besides diabetes)
The participant is, in the opinion of the investigator, unlikely to be able to complete all study requirements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Walhalla?

Yes, this clinical trial (NCT07731399) has an active research site in Walhalla, SC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 2 Diabetes Treatment Options in Walhalla, SC

If you're searching for type 2 diabetes treatment options in Walhalla, SC, this clinical trial (NCT07731399) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Walhalla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 2 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Walhalla, SC

See all pulmonary embolism clinical trials recruiting in Walhalla — not just this study.

Browse Pulmonary Embolism Trials in Walhalla

Ready to Join in Walhalla?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Walhalla, SC